SOLIQUA® 100/33 (insulin glargine and lixisenatide) injection 100 Units/mL and 3
View full Prescribing Information at http://bit.ly/2peoQz6. For US residents only. Sanofi is a pharmaceutical company. You should always consult your doctor.
2.
Welcome to the SOLIQUA 100/33 page, created under the direction and financial sponsorship of Sanofi. We want this to be a helpful resource for people taking SOLIQUA 100/33 or for those looking for information. All users must comply with Facebook’s Terms of Use (https://www.facebook.com/terms.php) and the Sanofi Rules of Engagement. If you have any questions regarding these rules or our us
e of Facebook, please contact us directly at https://www.sanofi.us/en/contact-us. Rules of Engagement
This page is intended to provide information for US residents in English regarding SOLIQUA 100/33. This page is not intended as a forum for reporting Sanofi or other companies’ products’ side effects associated with the use of prescription drugs. We reserve the right to block users from this page who violate the Rules of Engagement. We reserve the right to remove this page and its contents at any time. Please check often for updates, as we reserve the right, in our sole discretion, to modify these Rules of Engagement at any time. Your use of this page indicates your acceptance of, and any revisions to, these terms.
1. From time to time this page may contain information related to various health and medical conditions and their treatment. Such information is not meant to be a substitute for the advice provided by your doctor. You should not use the information for diagnosing a health problem or disease. Sanofi can only confirm the accuracy of the information we post on this page and does not verify, approve or endorse information shared by visitors and does not warrant their accuracy. Caution should be used before relying on any particular statements or opinions expressed outside of this page.
3. This is not an interactive or response enabled page. Therefore, commenting, and direct messaging are turned off. To learn more about SOLIQUA 100/33 please visit www.soliqua100-33.com or call 1-800-981-2491.
4. If you, or someone you know, have possibly experienced a side effect while taking any Sanofi product, please contact us at 1-800-633-1610. You are also encouraged to report side effects of prescription drugs to the FDA. To do so, visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. MAT-US-2006948-v5.0-08/2023
